Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-13

Clinical Trial Update: Non-Steroidal Anti-Inflammatory Drug (NSAID) Response and Central Sensitization of Pain in Women With Dysmenorrhea [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing how NSAIDs influence pain response and central sensitization in women with dysmenorrhea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (Non-steroidal anti-inflammatory drugs)

Snippet

Sponsor: Mclean Hospital | Conditions: Dysmenorrhea, Menstrual Pain | Phase 4 | Status: COMPLETED